Saturday, March 2, 2019
Juniper Hotel Cupertino
Jack Schim, MD, APC
Harmeet Sachdev, MD
Wednesday, February 27, 2019
Anchusa, Lower Level
Kerry Knievel, DO
Rashmi Halker Singh, MD, FAHS
Manhattan, New York
Wednesday, June 26, 2019
Matthew Robbins, MD, FAAN, FAHS
Lawrence Newman, MD
Rochester, New York
Thursday, June 6, 2019
Staybridge Suites Rochester University
Raissa Villanueva, MD, MPH
Melissa Rayhill, MD, FAHS
Friday, July 26, 2019
Marriott Marquis Houston
Randolph W. Evans, MD
William S. Gilmer, MD, PA
Traverse City, Michigan
Friday, July 12, 2019
Wade Cooper, DO
Jordan Taylor, DO
Location Coming Soon
Location Coming Soon
Welcome and Session Overview
The New Era of Migraine Treatment
Cases in Episodic and Chronic Migraine
Question and Answer Session
This activity is designed for general neurologists. Other healthcare professionals, including physician assistants, nurse practitioners, nurses, and pharmacists, who treat patients with headache may also benefit from participation in the educational activity.
Paradigm shift, or shattered? The thinking around both preventive and acute treatment of migraine is amidst a radical change. From a new class of treatment targeting disease-specific pathophysiology to emerging therapies incorporating neuromodulatory devices, practicing clinicians will get up to speed on key treatment advances transforming migraine care. A case series will demonstrate how new information can be placed into practice.
Upon completion of this activity, participants should be able to:
Describe new advances in the pathophysiology of migraine, a chronic neurologic disease.
Develop treatment plans in line with standards of practice for acute and preventive management of episodic and chronic migraine.
Discuss unmet patient needs and burden of episodic and
Analyze safety and efficacy data for emerging therapies in acute and preventive treatment of migraine relative to current standards and clinically meaningful outcomes.
CREDIT DESIGNATION STATEMENT
Forefront Collaborative designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). All additional planning committee members, reviewers, and Forefront Collaborative staff have nothing to disclose. Full disclosures will be listed before each presentation.
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.
Forefront Collaborative complies with the Americans with Disabilities Act and will make every reasonable effort to accommodate your request. For special requests, please call Krista Jaworski at 812.340.4274 prior to this activity.
The views and opinions expressed in this activity are those of the Activity Chair and Steering Committee and do not necessarily reflect the views or recommendations of Forefront Collaborative or Lilly.